Hypermarcas (HYPMY) Projected to Announce Earnings on Thursday

Hypermarcas (OTCMKTS:HYPMY) will likely be releasing its results after the market closes on Thursday, August 6th. Analysts expect Hypermarcas to post earnings of $0.14 per share and revenue of $466.4080 million for the quarter.

Hypermarcas Trading Up 1.0%

Hypermarcas stock opened at $4.22 on Tuesday. Hypermarcas has a twelve month low of $3.71 and a twelve month high of $5.50. The stock has a 50 day moving average of $4.11 and a two-hundred day moving average of $4.37. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 8.79 and a beta of 0.70.

Analyst Upgrades and Downgrades

HYPMY has been the topic of a number of analyst reports. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Hypermarcas has an average rating of “Buy”.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.